Burrrer Wart Remover

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available data.

Uses and Indications

This drug is indicated for the removal of common warts and plantar warts.

Limitations of Use: There are no teratogenic or nonteratogenic effects mentioned associated with this drug.

Dosage and Administration

Healthcare professionals are advised to apply the liquid formulation using a brush, ensuring that the affected area is thoroughly covered. After application, it is essential to allow the formulation to remain on the skin until it transforms into a mask.

For optimal results, the application should be performed daily for a minimum duration of two weeks, or until the skin appears smooth. In cases of more severe conditions, an extended treatment period may be necessary to achieve the desired outcome.

Contraindications

Use of this product is contraindicated in the following situations:

Application on the facial or eye area is prohibited due to the potential for irritation and adverse reactions. Additionally, the product should not be applied to damaged or cut skin, including wounds, grazes, eczema, or sunburn, as this may exacerbate the condition or lead to further complications. Furthermore, individuals with a known allergy to this product should avoid its use to prevent allergic reactions.

Warnings and Precautions

For external use only, this product must be kept away from fire and flame. It is essential to apply it solely to the affected area and ensure it is stored out of reach of children to prevent accidental ingestion or misuse.

In terms of general precautions, healthcare professionals should advise patients to seek immediate medical assistance or contact a Poison Control Center (1-800-222-1222) if the product is swallowed. The product is contraindicated for use on the facial or eye area and should not be applied to damaged or cut skin, including wounds, grazes, eczema, or sunburn. Additionally, individuals with a known allergy to this product should refrain from its use.

Patients should be instructed to discontinue use and consult a healthcare provider if any irritation or rash develops following application. In cases of ingestion, immediate medical help should be sought, or the Poison Control Center should be contacted without delay.

Side Effects

Patients using this product should be aware of several important warnings and precautions. The product is intended for external use only and should be applied solely to the affected area. It is crucial to keep the product away from fire and flame, and it should be stored out of reach of children to prevent accidental ingestion or misuse.

In the event that irritation or a rash occurs, patients are advised to discontinue use immediately and consult a healthcare professional. Additionally, individuals who are pregnant or breastfeeding should seek medical advice before using this product. For children over three years of age, adult supervision is recommended during use, while those under three years old should consult a doctor prior to application.

These precautions are essential to ensure the safe and effective use of the product.

Drug Interactions

There are no specific drug interactions reported for this medication. Additionally, no laboratory test interactions have been identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Burrrer Wart Remover (wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients over three years old should use this medication under adult supervision. For children under three years old, it is recommended to consult a healthcare professional prior to use. Additionally, it is important to keep this medication out of reach of children to ensure safety.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and breastfeeding.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication while breastfeeding. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage in the provided sections of the Summary of Product Characteristics (SPL), healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdosage.

Recommended Actions In the event of an overdosage, it is essential for healthcare providers to assess the patient's clinical status and initiate appropriate supportive care. Monitoring of vital signs and symptomatic treatment should be implemented as necessary.

Potential Symptoms While specific symptoms of overdosage are not detailed, healthcare professionals should remain vigilant for any unusual or severe reactions that may arise, given the pharmacological profile of the medication.

Management Procedures In the absence of specific antidotes or treatment protocols, healthcare professionals should consult local poison control centers or toxicology experts for guidance on the management of overdosage cases. It is crucial to document the incident thoroughly and report any adverse effects to the relevant regulatory authorities as per local guidelines.

Overall, due diligence and a proactive approach are recommended in managing potential overdosage situations, ensuring patient safety and optimal care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

Skin discoloration has been reported in postmarketing experience, occurring during or after the use of the product. These events have been documented through voluntary reports and surveillance programs.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 if the product is swallowed. It is important to instruct patients to discontinue use and consult a healthcare provider if they experience any irritation or rash.

While using the product, patients must be cautioned to avoid contact with the eyes, ears, mouth, and any open or damaged skin areas. In the event of contact with the eyes, patients should rinse their eyes thoroughly with water.

Healthcare providers should recommend that patients consult a doctor before using the product if they are pregnant or breastfeeding. Additionally, it is essential to inform patients that children over three years old should use the product under adult supervision, while those under three years old should seek medical advice prior to use.

Storage and Handling

The product is supplied in a sealed bottle, which should be stored in a shaded area to protect it from light exposure. It is essential to avoid excessive heat, with a maximum temperature limit of 37°C (99°F) to ensure the integrity of the product. Proper storage conditions are crucial for maintaining the quality and efficacy of the product.

Additional Clinical Information

The product is administered topically. Clinicians should advise that children over three years old may use the product under adult supervision, while those under three years old should consult a doctor prior to use.

No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Burrrer Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)